<code id='3D9709078E'></code><style id='3D9709078E'></style>
    • <acronym id='3D9709078E'></acronym>
      <center id='3D9709078E'><center id='3D9709078E'><tfoot id='3D9709078E'></tfoot></center><abbr id='3D9709078E'><dir id='3D9709078E'><tfoot id='3D9709078E'></tfoot><noframes id='3D9709078E'>

    • <optgroup id='3D9709078E'><strike id='3D9709078E'><sup id='3D9709078E'></sup></strike><code id='3D9709078E'></code></optgroup>
        1. <b id='3D9709078E'><label id='3D9709078E'><select id='3D9709078E'><dt id='3D9709078E'><span id='3D9709078E'></span></dt></select></label></b><u id='3D9709078E'></u>
          <i id='3D9709078E'><strike id='3D9709078E'><tt id='3D9709078E'><pre id='3D9709078E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:292
          Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT
          Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

          WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

          Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

          advertisement

          Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          The Biogen Aduhelm mess could happen again
          The Biogen Aduhelm mess could happen again

          BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Updated Covid vaccine has 54% effectiveness, new study suggests

          AhealthcareworkerfillsasyringewithPfizer'sCovid-19vaccine.LynneSladky/APNewdatareleasedThursdaybythe